Condition
Acute Graft-Versus-Host Reaction Following Bone Marrow Transplant
Total Trials
2
Recruiting
0
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
P 1 (1)
Trial Status
Active Not Recruiting1
Unknown1
Clinical Trials (2)
Showing 2 of 2 trials
NCT04692181Phase 1Active Not RecruitingPrimary
SYN-004 Safety and Tolerability in Allo-HCT Subjects
NCT03172455Unknown
Early Access Program Using Alpha 1 Antitrypsin Infusion for Patients With Steroid Refractory Acute GvHD After Hematopoietic Stem Cell Transplantation (HSCT)
Showing all 2 trials